Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ID › Coeur D Alene › NPI 1992798409
Hospital

Kootenai Health, INC.

Kootenai Health, INC. was paid $6.94M by Medicaid between Jan 2018 and Dec 2024, across 264 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 8.4% of everything it billed.

33Billing provider infoKOOTENAI HEALTH, INC.
COEUR D ALENE, ID 83814
33aNPI1992798409assigned 08/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.94M
24GClaims383,803
24DCodes billed264
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Idaho

Rank by total paid#2 of 12
Median peer was paid$3.12M
This provider vs. median2.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018107,832$2.20M
201997,416$2.04M
202066,895$1.56M
202125,746$301K
202228,353$299K
202332,998$307K
2024incomplete24,563$237K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
97530 Therapeutic activities, direct patient contact, each 15 minutes 8.4% 11,135 3,859 $585K
J1745 Injection, infliximab, excludes biosimilar, 10 mg 7.4% 308 270 $514K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 6.3% 8,100 2,653 $435K
74177 Computed tomography, abdomen and pelvis; with contrast material 6.2% 3,593 3,350 $434K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.2% 6,758 6,034 $429K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.4% 5,512 5,014 $373K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.8% 37,648 28,198 $330K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 2.6% 1,701 1,636 $183K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.5% 7,605 2,506 $172K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 2.4% 2,282 2,067 $167K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.3% 2,498 2,274 $159K
70450 Computed tomography, head or brain; without contrast material 2.2% 2,949 2,726 $153K
252 more codes
87631 2.2% 1,403 $152K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.8% 3,128 $122K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.7% 2,346 $118K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.6% 2,144 $113K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.5% 28,282 $107K
96361 Intravenous infusion, hydration; each additional hour 1.4% 766 $95K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.2% 471 $85K
80053 Comprehensive metabolic panel 1.2% 16,223 $84K
92523 1.2% 612 $83K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 2,281 $82K
92526 1.1% 1,418 $78K
71046 Radiologic examination, chest; 2 views <1% 6,661 $60K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,831 $56K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 385 $52K
76830 Ultrasound, transvaginal <1% 773 $45K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 699 $40K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 789 $39K
84112 <1% 495 $38K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 534 $35K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 657 $34K
97166 <1% 681 $34K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,071 $33K
97162 <1% 837 $32K
90853 Group psychotherapy (other than of a multiple-family group) <1% 503 $32K
80048 Basic metabolic panel (calcium, ionized) <1% 7,588 $32K
71275 Computed tomographic angiography, chest, with contrast material <1% 386 $31K
36415 Collection of venous blood by venipuncture <1% 21,572 $30K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 729 $30K
97161 <1% 595 $29K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,241 $29K
J2469 Injection, palonosetron hcl, 25 mcg <1% 223 $29K
80047 <1% 4,270 $28K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 385 $28K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 579 $27K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 235 $27K
93017 <1% 444 $25K
92610 <1% 430 $25K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 1,028 $25K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 421 $24K
84443 Thyroid stimulating hormone (TSH) <1% 3,382 $24K
82948 <1% 8,633 $23K
93976 <1% 152 $23K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,286 $22K
76770 <1% 470 $22K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 306 $22K
72125 Computed tomography, cervical spine; without contrast material <1% 541 $21K
81025 <1% 4,281 $20K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 631 $20K
G0378 Hospital observation service, per hour <1% 1,002 $20K
81003 <1% 11,184 $19K
76801 <1% 375 $19K
96375 Therapeutic injection; each additional sequential IV push <1% 3,986 $19K
76642 <1% 567 $19K
84484 <1% 5,290 $18K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 817 $18K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 379 $16K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 192 $15K
83690 <1% 4,659 $15K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 5,886 $14K
83880 <1% 1,343 $13K
87040 <1% 2,272 $13K
97113 <1% 362 $13K
83735 <1% 4,760 $13K
85610 <1% 7,365 $12K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 178 $12K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 372 $11K
83605 <1% 2,276 $11K
80076 <1% 2,326 $11K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 374 $11K
73221 <1% 89 $10K
83874 <1% 1,775 $10K
97750 <1% 241 $10K
71250 <1% 273 $10K
J2785 Injection, regadenoson, 0.1 mg <1% 244 $10K
73562 <1% 705 $9K
73110 <1% 558 $9K
74018 <1% 767 $9K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,555 $9K
70551 Magnetic resonance imaging, brain; without contrast material <1% 115 $8K
73630 <1% 689 $8K
71045 Radiologic examination, chest; single view <1% 2,385 $8K
73610 <1% 620 $8K
70486 <1% 163 $8K
84702 <1% 582 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,767 $7K
99490 Ccm add 20min <1% 1,527 $7K
87641 <1% 366 $7K
73130 <1% 540 $7K
73030 <1% 710 $7K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 94 $6K
86850 <1% 1,047 $6K
96415 <1% 97 $6K
97116 <1% 298 $6K
20610 <1% 295 $6K
72110 <1% 353 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 172 $5K
82550 <1% 1,727 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,983 $5K
77066 Tomosynthesis, mammo <1% 74 $5K
87430 <1% 441 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 144 $5K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 359 $5K
87077 <1% 1,039 $5K
87186 <1% 900 $5K
85380 <1% 836 $5K
84520 <1% 1,911 $4K
73502 <1% 428 $4K
77065 Tomosynthesis, mammo <1% 87 $4K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 45 $4K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 907 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,437 $4K
99214 Doctor's office visit, returning patient (more involved) <1% 317 $4K
87070 <1% 672 $4K
82803 <1% 325 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 2,997 $4K
72141 <1% 45 $4K
86900 <1% 1,179 $4K
76536 <1% 57 $4K
36592 <1% 484 $4K
86901 <1% 1,179 $4K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 617 $4K
74230 <1% 47 $3K
86140 <1% 1,090 $3K
85730 <1% 986 $3K
77002 <1% 105 $3K
J1453 Injection, fosaprepitant, 1 mg <1% 19 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,132 $3K
86780 <1% 220 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,737 $3K
70491 <1% 37 $3K
Q3014 Telehealth originating site facility fee <1% 722 $3K
76819 Fetal biophysical profile; without non-stress testing <1% 70 $3K
87081 <1% 465 $3K
93880 <1% 66 $3K
36416 <1% 3,165 $3K
77080 <1% 365 $2K
70544 <1% 26 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 59 $2K
87210 <1% 543 $2K
82728 <1% 381 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,569 $2K
80061 Lipid panel <1% 501 $2K
87205 <1% 693 $2K
85027 <1% 1,691 $2K
87634 <1% 28 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 618 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 31 $2K
97535 Self-care/home management training, each 15 minutes <1% 63 $2K
G0008 Administration of influenza virus vaccine <1% 853 $2K
85651 <1% 608 $2K
90686 <1% 468 $2K
97010 <1% 579 $2K
84100 <1% 462 $2K
97165 <1% 27 $1K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 141 $1K
92611 <1% 41 $1K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 28 $1K
87075 <1% 210 $1K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 13 $1K
73080 <1% 87 $1K
82565 <1% 658 $1K
72050 <1% 54 $998.60
81001 <1% 2,344 $966.95
85055 <1% 43 $927.63
84145 <1% 45 $873.19
82731 <1% 16 $858.82
73140 <1% 64 $803.51
73590 <1% 69 $728.72
72100 <1% 43 $659.51
81002 <1% 325 $655.07
82570 <1% 972 $651.61
J0585 Injection, onabotulinumtoxina, 1 unit <1% 14 $604.39
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,064 $593.72
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 30 $545.50
82962 <1% 480 $540.05
72082 <1% 14 $530.04
73090 <1% 47 $526.25
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 290 $520.02
84439 <1% 83 $500.87
J1650 Injection, enoxaparin sodium, 10 mg <1% 236 $485.06
76937 <1% 35 $453.87
83615 <1% 95 $449.58
80069 <1% 179 $395.98
82947 <1% 93 $390.26
76870 <1% 14 $383.72
73564 <1% 33 $383.12
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 236 $345.43
G0009 Administration of pneumococcal vaccine <1% 108 $297.49
72072 <1% 28 $281.43
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,701 $277.98
36591 <1% 125 $268.80
99152 <1% 177 $267.48
83540 <1% 135 $236.04
82274 <1% 28 $235.30
76857 <1% 13 $234.78
90670 <1% 16 $231.57
90662 <1% 208 $219.78
73521 <1% 12 $215.00
77063 Screening digital breast tomosynthesis, bilateral <1% 1,070 $204.84
74022 <1% 13 $193.81
99213 Doctor's office visit, returning patient (routine) <1% 16 $187.58
83550 <1% 94 $174.14
74019 <1% 12 $164.75
85014 <1% 73 $162.49
82330 <1% 96 $152.95
85652 <1% 165 $144.36
77001 <1% 15 $132.26
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 543 $125.00
C1769 Guide wire <1% 64 $123.26
85007 <1% 602 $121.34
96376 <1% 556 $110.24
80051 <1% 15 $108.49
99153 Mod sedat endo service >5yrs <1% 57 $87.08
J7120 Ringers lactate infusion, up to 1000 cc <1% 1,099 $75.14
0296T <1% 12 $73.80
90732 <1% 15 $71.21
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 367 $70.66
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 278 $65.57
84156 <1% 53 $63.63
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 17 $56.94
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 28 $51.85
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 108 $50.52
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 54 $45.91
84550 <1% 14 $41.09
99487 Ccm add 20min <1% 17 $40.59
Q9957 Injection, perflutren lipid microspheres, per ml <1% 267 $40.33
J2270 Injection, morphine sulfate, up to 10 mg <1% 266 $26.60
J1245 Injection, dipyridamole, per 10 mg <1% 31 $18.90
J2704 Injection, propofol, 10 mg <1% 1,096 $17.32
82077 <1% 121 $16.22
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 12 $8.03
82043 <1% 24 $5.92
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 136 $5.09
84295 <1% 109 $1.56
82247 <1% 20 $1.56
84155 <1% 30 $1.56
84075 <1% 20 $1.56
82040 <1% 19 $1.56
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 20 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 13 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 15 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 83 $0.00
J1200 Injection, diphenhydramine hcl, up to 50 mg 0% 29 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 248 $0.00
80320 0% 167 $0.00
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 98 $0.00
82435 0% 94 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 165 $0.00
84132 0% 79 $0.00
J2060 Injection, lorazepam, 2 mg 0% 16 $0.00
85018 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNESS, JON (CEO)
Same official

Other billing entities under NESS, JON

Full network →
ProviderLocationPaid
Kootenai Health, INC.Coeur D Alene, ID$6.64M
Kootenai Health, INC.Coeur D Alene, ID$2.59M
Kootenai Health, INC.Coeur D Alene, ID$22K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.